Evotec (OTCMKTS:EVTCY) Sets New 1-Year Low at $3.24

Evotec SE (OTCMKTS:EVTCY) reached a new 52-week low on Monday . The company traded as low as $3.24 and last traded at $3.27, with a volume of 62743 shares changing hands. The stock had previously closed at $3.39.

Evotec Stock Down 3.5 %

The company has a market capitalization of $1.08 billion, a price-to-earnings ratio of 8.27 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The business has a fifty day simple moving average of $3.82 and a two-hundred day simple moving average of $5.13.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.